Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 283-284, September 2009

Introduction: CML in the imatinib era

  • R. Hehlmann (Professor Dr. med.)

      Affiliations

    • Corresponding Author InformationTel.: +49 621 383 6931; Fax: +49 621 383 6932.

Medizinische Fakultäet Mannheim der Universitäet Heidelberg, Pettenkoferstr. 22, 68169 Mannheim, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00072-3

doi:10.1016/j.beha.2009.10.002

Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 283-284, September 2009

Article Tools

* Image Usage & Resolution